ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
87.685
-0.54%
Bitcoin
62,846.00
-0.88%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Medivir Ab (0GP7) Quote

Medivir Ab

Medivir Ab (0GP7)

LSE
41.70
0.00
(0.00%)
Closed April 28 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
41.70
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
41.70 52 Week Range 41.70
Market Cap
45.79M
Previous Close
41.70
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,132
Shares Outstanding
55,841,000
Dividend Yield
-
PE Ratio
-0.51
Earnings Per Share (EPS)
-1.6
Revenue
9M
Net Profit
-89.3M

About Medivir Ab

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
www.medivir.se
Headquarters
Huddinge, Swe
Founded
1992
Medivir Ab is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0GP7. The last closing price for Medivir Ab was SEK41.70. Over the last year, Medivir Ab shares have traded in a share price range of SEK 41.70 to SEK 41.70.

Medivir Ab currently has 55,841,000 shares outstanding. The market capitalization of Medivir Ab is SEK45.79 million. Medivir Ab has a price to earnings ratio (PE ratio) of -0.51.

0GP7 Latest News

More News

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox PR Newswire STOCKHOLM, Jan. 15, 2024 STOCKHOLM, Jan. 15, 2024...

January 15 2024
PR Newswire (US)

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study PR Newswire STOCKHOLM, Jan. 4, 2024 STOCKHOLM, Jan. 4, 2024...

January 04 2024
PR Newswire (US)

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan PR Newswire STOCKHOLM, Dec. 19, 2023 Sustained disease control...

December 19 2023
PR Newswire (US)

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval PR Newswire STOCKHOLM, Dec. 13, 2023 STOCKHOLM...

December 13 2023
PR Newswire (US)

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB...

December 06 2023
PR Newswire (US)

Medivir to present at the Carlsquare Equity Research Investor Day

Medivir to present at the Carlsquare Equity Research Investor Day PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical...

December 06 2023
PR Newswire (US)

Bulletin from Extraordinary General Meeting in Medivir AB (publ)

Bulletin from Extraordinary General Meeting in Medivir AB (publ) PR Newswire STOCKHOLM, Dec. 1, 2023 STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Today on 1 December 2023, Medivir AB (publ) (the...

December 01 2023
PR Newswire (US)

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC PR Newswire STOCKHOLM, Nov. 27, 2023 STOCKHOLM, Nov. 27...

November 27 2023
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120041.741.741.7213241.7DE
260041.741.741.7231641.7DE
520041.741.741.7225641.7DE
1560041.741.741.7433841.7DE
2600041.741.741.7431241.7DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

Discussion

View Full Feed
ironhammer ironhammer 3 minutes ago
thanks Eli
CGAC
Dingbatt Dingbatt 3 minutes ago
I was too busy planning the battle of Thermopylae making sure all the spears and swords were facing the right direction
RNVA
mrplmer mrplmer 4 minutes ago
Only if it's another Rett scenario. And if it is Missling will be sued into his grave.
AVXL
zakattack zakattack 4 minutes ago
so 100 mill isn't enought?
PSRU
Nelson2 Nelson2 5 minutes ago
So listen up. Your posts Never really bothered me. Funny in a way
I have never posted this but I too sold at .12 cents. I bought back in with an average cost of .5 cents. We shall see how this pans out.
So, yes I know the game

GLTU
CLNV
joe botts joe botts 5 minutes ago
It's REVOKED
BoscoLives21 BoscoLives21 5 minutes ago
The only thing vanishing is 1812’s beer — but they can brew more!
$$$KEGS$$$
KEGS
Dingbatt Dingbatt 6 minutes ago
Funack no sense asking a Dingbatt why that was the plan you need to ask Marco Polo Herodotus or Aristotle
RNVA
Jetmek_03052 Jetmek_03052 6 minutes ago
I believe it's because;

1. He wants to keep investors informed about the status of the litigation.
2. He wants to let investors know that some PTAB FWD final decisions are being appealed, and the status of those appeals.

The PTAB is NOT the final word, by any m
NLST
PennyMillions852 PennyMillions852 6 minutes ago
Monday! $CBIA🚀🚀🚀
CBIA
casper6 casper6 7 minutes ago
IGP$ is where you should have been playing if your money wasn't all tied up here and with all your other losers.
I have been playing it.
I told you it would be in play until they figured out "what was really going on" I did some good DD there.
Confirmations I was looking for in
EGOC
HippyTrades HippyTrades 7 minutes ago
The thing is they just diluted the O/S 1.1b at the start of the month. So it would have to be significantly more than that alone to make any difference here.
PSRU
movinon movinon 9 minutes ago
This was in ST.
as it relates to NSAVx, we were informed today that our required local director for the
NSAV Singapore subsidiary, has been approved and the Money Transmitter license will be issued
later this week. NSAV will make a formal announcement once the license is issued
NSAV
t1215s t1215s 9 minutes ago
Boris, Shaq has a person he’s hired to follow him wherever he goes to help him get out and get in the Ferrari 😂

GLTA-Ts😉
COOP
10thMountain 10thMountain 9 minutes ago
Thx and ok I apologize
TDRK
Helter Skelter Helter Skelter 9 minutes ago
👉️ Dr Mike Chan cannot fail... 😺 It's just not possible.

Prof. Dato’ Sri Dr. Mike K.S. Chan is an author, educator and pioneer of Organotherapy, Cellular Therapy and Cell Membrane Therapy in Europe and Asia since the early 1980s. He founded and funde
NIVF
zakattack zakattack 10 minutes ago
guy showed his hand alrady i doubt there's more
PSRU
Nightdaytrader Nightdaytrader 10 minutes ago
I just hope before Erhc and offor lose everything in eez and jdz, they cut a deal and get something for shareholders.. anything is better than nothing.. especially after all these yrs..

Nd9
ERHE
dealerschool2006 dealerschool2006 10 minutes ago
I read FX empire as well...NG intelligence costs $$$ so i gave them an email address to read the full article...twitter has some useful players on there with helpful info...
jabweatherman jabweatherman 10 minutes ago
Ok I mean a GOOD surprise lol
PSRU
dealerschool2006 dealerschool2006 12 minutes ago
The $boil and $kold funds roll two #natgas futures contacts out because it theoretically can reduce roll yield decay. You can see this has actually been the case since the last roll as N24 has gone down less than M24.

https://twitter.com/DiveBomb321/status/1784566257439670392
BOIL KOLD
Boris the Spider Boris the Spider 13 minutes ago
AZ, re: my new escrow 'vette. Will it be hard for me to get in and out? License plate will be WAMU

I recently saw Shaq driving down the freeway between LA and San Diego in a tiny red Ferrari.....license plate: SHAQ.
I got in the left lane next to him and he looked over at
COOP
B402 B402 13 minutes ago
Worthless classes people can't make a living at with the degree...This isn't even the the existential ones....

You made the top ten, number 3
https://www.careeraddict.com/useless-degrees


More
https://www.universities.com/resources/most-useless-degr

Your Recent History

LSE
0GP7
Medivir Ab
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved